Inside information: Bioretec estimates that the approval of the European market authorization for the biodegradable RemeOs™ trauma screw will move to the first quarter of 2024
Bioretec Ltd Inside information 18 October 2023 at 20:00 p.m. EESTThe European market authorization process for Bioretec Ltd's RemeOs™ trauma screw, a pioneer in biodegradable orthopedic implants, still continues by the Notified body (Dekra). The company estimates that the CE mark for the trauma screw will not be obtained during the end of 2023, as previously expected. Bioretec now estimates that the European market authorization for the product will be obtained during the first quarter of 2024. The reason for the schedule change is not related to the company but to the Notified Body’s